Immatics IMTX
NASDAQ IMTX
$7.54 -0.15 (-1.95%)
At close: Oct 22, 2026 · 4:00 PM EDT

Immatics (IMTX) Share-based Compensation (IS) (2019 - 2020)

Updated

Analysis

Immatics (IMTX) Share-based Compensation (IS) (2019 - 2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn -
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn -
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn -
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn -
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn -
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn -
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn -
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn -
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn -
10 Immatics 1.01 Bn -1.01 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2020 9.57 Mn
Jun 30, 2019 231,469.65
API Access

Immatics Share-based Compensation (IS) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation-is&ticker=IMTX&period=max&api_key=YOUR_API_KEY